Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia-Reference-Cited by-同舟云学术

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

Published:2015-01-21 Issue:2 Volume:90 Page:97-99
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Khawaja Muhammad Rizwan¹,Perkins Susan M.²,Schwartz Jennifer E.¹,Robertson Michael J.¹,Kiel Patrick J.¹,Sayar Hamid¹,Cox Elizabeth A.¹,Vance Gail H.³,Farag Sherif S.¹³⁴,Cripe Larry D.¹,Nelson Robert P.¹⁵

Affiliation:

1. Division of Hematology/Oncology, Department of Medicine; Indiana University School of Medicine, Melvin and Bren Simon Cancer Center; Indianapolis Indiana

2. Department of Biostatistics; Indiana University School of Medicine; Indianapolis Indiana

3. Department of Medical and Molecular Genetics; Indiana University School of Medicine; Indianapolis Indiana

4. Department of Microbiology and Immunology; Indiana University School of Medicine; Indianapolis Indiana

5. Department of Pediatrics; Indiana University School of Medicine; Indianapolis Indiana

Funder

Indiana University and Melvin and Bren Simon Cancer Center

Publisher

Wiley

Subject

Hematology

Reference13 articles.

1. Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy;Champlin;Br J Haematol,2000

2. Defining the intensity of conditioning regimens: Working definitions;Bacigalupo;Biol Blood Marrow Transplant,2009

3. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses;Childs;Blood,1999

4. Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia;Nelson;Bone Marrow Transplant,2010

5. Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: Dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation;Lima;Blood,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities;Bone Marrow Transplantation;2022-09-12

2. A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes;Health Science Reports;2021-05-07